CHG-2021-0200
Formulation Change for Erenumabix. Labeling Change for Erenumabix — routine update. Impacts 2 markets and 5 variations.
Change Number
CHG-2021-0200
Type
Formulation Change
Product
Status
Draft
Owner
Tomoko Ikeda
Initiated
2023-10-31
Description
Labeling Change for Erenumabix — routine update
Impacted Markets (2)
GB — United KingdomKR — South Korea
Impacted Modules
2.3.P3.2.P4.2.13.2.P.3
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|